BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38056508)

  • 1. A Targeted, Personalized Management Strategy in Advanced Penile Squamous Cell Carcinoma.
    Holland LC; Gerald TS; Brooks B; Margulis V
    Urology; 2024 Feb; 184():71-74. PubMed ID: 38056508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding genomics and the immune environment of penile cancer to improve therapy.
    Aydin AM; Chahoud J; Adashek JJ; Azizi M; Magliocco A; Ross JS; Necchi A; Spiess PE
    Nat Rev Urol; 2020 Oct; 17(10):555-570. PubMed ID: 32812000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
    Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI; Ryan CJ; McKay RR; Master VA; Bilen MA
    Cancer; 2023 Dec; 129(24):3884-3893. PubMed ID: 37565840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
    Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
    J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
    Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
    Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma.
    Chahoud J; Gleber-Netto FO; McCormick BZ; Rao P; Lu X; Guo M; Morgan MB; Chu RA; Martinez-Ferrer M; Eterovic AK; Pickering CR; Pettaway CA
    Clin Cancer Res; 2021 May; 27(9):2560-2570. PubMed ID: 33441293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma.
    Hu X; Chen M; Liu W; Li Y; Fu J
    Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.
    Ribera-Cortada I; Guerrero-Pineda J; Trias I; Veloza L; Garcia A; Marimon L; Diaz-Mercedes S; Alamo JR; Rodrigo-Calvo MT; Vega N; López Del Campo R; Parra-Medina R; Ajami T; Martínez A; Reig O; Ribal MJ; Corral-Molina JM; Jares P; Ordi J; Rakislova N
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Advanced Penile Cancer.
    Chahoud J; Kohli M; Spiess PE
    Mayo Clin Proc; 2021 Mar; 96(3):720-732. PubMed ID: 33308870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital lichen sclerosus/balanitis xerotica obliterans in men with penile carcinoma: a critical analysis.
    Philippou P; Shabbir M; Ralph DJ; Malone P; Nigam R; Freeman A; Muneer A; Minhas S
    BJU Int; 2013 May; 111(6):970-6. PubMed ID: 23356463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.
    McDaniel AS; Hovelson DH; Cani AK; Liu CJ; Zhai Y; Zhang Y; Weizer AZ; Mehra R; Feng FY; Alva AS; Morgan TM; Montgomery JS; Siddiqui J; Sadis S; Bandla S; Williams PD; Cho KR; Rhodes DR; Tomlins SA
    Cancer Res; 2015 Dec; 75(24):5219-27. PubMed ID: 26670561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma.
    Hu X; Chen M; Li Y; Wang Y; Wen S; Jun F
    Oncol Rep; 2019 Feb; 41(2):1091-1100. PubMed ID: 30535485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
    Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
    World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden.
    Necchi A; Spiess PE; Costa de Padua T; Li R; Grivas P; Huang RSP; Lin DI; Danziger N; Ross JS; Jacob JM; Sager RA; Basnet A; Li G; Graf RP; Pavlick DC; Bratslavsky G
    JAMA Netw Open; 2023 Dec; 6(12):e2348002. PubMed ID: 38150257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational landscape of penile squamous cell carcinoma in a Chinese population.
    Wang Y; Wang K; Chen Y; Zhou J; Liang Y; Yang X; Li X; Cao Y; Wang D; Luo L; Li B; Li D; Wang L; Liang Z; Gao C; Wang Q; Lv Q; Li Z; Shi Y; Niu H
    Int J Cancer; 2019 Sep; 145(5):1280-1289. PubMed ID: 31034097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathogenesis of Penile Squamous Cell Carcinoma: Current Understanding and Potential Treatment Implications.
    Keller BA; Pastukhova E; Lo B; Sekhon HS; Flood TA
    Arch Pathol Lab Med; 2023 Jun; 147(6):722-734. PubMed ID: 36136297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.
    Wei L; Li Z; Guo S; Ma H; Shi Y; An X; Huang K; Xiong L; Xue T; Zhang Z; Yao K; Luo J; Han H
    Cancer; 2024 May; 130(9):1650-1662. PubMed ID: 38157276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Molecular Profile of Penile Squamous Cell Carcinoma.
    McGregor BA; Sonpavde GP
    Clin Cancer Res; 2021 May; 27(9):2375-2377. PubMed ID: 33653819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune landscape and immunotherapy for penile cancer.
    Tang Y; Hu X; Wu K; Li X
    Front Immunol; 2022; 13():1055235. PubMed ID: 36524123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.